Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (11-20 of 416) with videos related to

Pageof 42
Sort By:
Expert Opinion on Investigational Drugs|July 18, 2012
Sorafenib for lung cancer: is the "Battle" still open?Emilio Bria, Sara Pilotto, Giampaolo Tortora
Journal of Thoracic Disease|October 22, 2019
Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?Umberto Malapelle, Antonio Rossi, Emilio Bria
JAMA Network Open|December 5, 2023
Extension of the SPIRIT 2013 Statement for Factorial Randomized Trials-A Step Toward Transparency and the Curse of InteractionLuca Mastrantoni, Gennaro Daniele, Emilio Bria
The New England Journal of Medicine|July 7, 2009
Cetuximab for metastatic colorectal cancerEmilio Bria, Federica Cuppone, Massimo Di Maio
Translational Lung Cancer Research|January 23, 2016
Platelets and their role in cancer evolution and immune systemNiki Karachaliou, Sara Pilotto, Emilio Bria, et al.
Interactive Cardiovascular and Thoracic Surgery|January 22, 2015
eComment. Does resected lymph-node number influence survival in non-small cell lung cancer?Giovanni Leuzzi, Filippo Lococo, Emilio Bria, et al.
Journal of Thoracic Disease|December 10, 2017
Tracking occult pN2 disease after mediastinal dissection in early stage lung cancerCristiano Benato, Sara Pilotto, Maurizio Infante, et al.
Cureus|September 2, 2024
Unique Ovarian Metastasis of Small-Cell Lung Cancer and Complete Response After Chemo-Immunotherapy: An Unusual Spread as a Predictor FactorFederico Monaca, Frediano Socrate Inzani, Armando Orlandi, et al.
JTO Clinical and Research Reports|April 27, 2023
Seize the Opportunity With Small Tissue Samples: The Tailor Teaches!Rocco Trisolini, Emilio Bria, Valeria Cetoretta, et al.
Expert Opinion on Pharmacotherapy|July 28, 2020
Has crizotinib significantly impacted non-small-cell lung cancer therapy?Emanuele Vita, Alessio Stefani, Ettore D'Argento, et al.
Pageof 42

Showing results (11-20 of 416) with videos related to

Sort By:
Pageof 42
Expert Opinion on Investigational Drugs|July 18, 2012
Sorafenib for lung cancer: is the "Battle" still open?Emilio Bria, Sara Pilotto, Giampaolo Tortora
Journal of Thoracic Disease|October 22, 2019
Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?Umberto Malapelle, Antonio Rossi, Emilio Bria
JAMA Network Open|December 5, 2023
Extension of the SPIRIT 2013 Statement for Factorial Randomized Trials-A Step Toward Transparency and the Curse of InteractionLuca Mastrantoni, Gennaro Daniele, Emilio Bria
The New England Journal of Medicine|July 7, 2009
Cetuximab for metastatic colorectal cancerEmilio Bria, Federica Cuppone, Massimo Di Maio
Translational Lung Cancer Research|January 23, 2016
Platelets and their role in cancer evolution and immune systemNiki Karachaliou, Sara Pilotto, Emilio Bria, et al.
Interactive Cardiovascular and Thoracic Surgery|January 22, 2015
eComment. Does resected lymph-node number influence survival in non-small cell lung cancer?Giovanni Leuzzi, Filippo Lococo, Emilio Bria, et al.
Journal of Thoracic Disease|December 10, 2017
Tracking occult pN2 disease after mediastinal dissection in early stage lung cancerCristiano Benato, Sara Pilotto, Maurizio Infante, et al.
Cureus|September 2, 2024
Unique Ovarian Metastasis of Small-Cell Lung Cancer and Complete Response After Chemo-Immunotherapy: An Unusual Spread as a Predictor FactorFederico Monaca, Frediano Socrate Inzani, Armando Orlandi, et al.
JTO Clinical and Research Reports|April 27, 2023
Seize the Opportunity With Small Tissue Samples: The Tailor Teaches!Rocco Trisolini, Emilio Bria, Valeria Cetoretta, et al.
Expert Opinion on Pharmacotherapy|July 28, 2020
Has crizotinib significantly impacted non-small-cell lung cancer therapy?Emanuele Vita, Alessio Stefani, Ettore D'Argento, et al.
Pageof 42